A PYMNTS Company

US: Anthem and Cigna boost spending on lobbying during merger review

By  |  June 16, 2016

As health insurance giants Cigna and Anthem seek regulatory approval for a controversial merger, they have been ramping up their spending on lobbying, enlisting an army of former government officials with ties to the key public officials who can influence the antitrust review process. The lobbying push comes as groups representing phyisicans and consumers have argued that the merger — which would create the largest private health insurance company in history — could raise premiums and limit medical care for more than 53 million people.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    An International Business Times analysis of lobbying records found that in 2015 — the year Cigna and Anthem announced the merger proposal — the companies spent more than $13.6 million combined on federal lobbying. That was a one-year increase of more than 17 percent in such spending, and a full 73 percent more than the two companies spent during the health industry’s epic lobbying blitz in 2009, when the Affordable Care Act was being negotiated.

    As Justice Department officials have been reviewing the merger proposal in 2015 and 2016, federal records show the companies specifically listing antitrust issues as a focus of their lobbying efforts. The records documenting the antitrust-related lobbying disclosed more than $8 million worth of lobbying spending.

    An Anthem spokesperson said there were several motivations for increasing its lobbying.

    Full Content: International Business Times

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.